37 results on '"Ponzoni, M."'
Search Results
2. Combination of the MEK inhibitor pimasertib with BTK or PI3K-delta inhibitors is active in preclinical models of aggressive lymphomas
3. A novel liposomal Clodronate depletes tumor-associated macrophages in primary and metastatic melanoma: Anti-angiogenic and anti-tumor effects
4. sTRAIL coupled to liposomes improves its pharmacokinetic profile and overcomes neuroblastoma tumour resistance in combination with Bortezomib
5. Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma
6. Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy
7. Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa
8. SC228 - How to maximize the diagnostic rate of endoscopic biopsy during flexible ureteroscopy for upper tract urothelial carcinoma
9. Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma
10. Primary brain CD30+ ALK1+ anaplastic large cell lymphoma (‘ALKoma’): the first case with a combination of ‘not common’ variants
11. Relevance of intraocular involvement in the management of primary central nervous system lymphomas
12. Angiogenesis and anti-angiogenesis in neuroblastoma
13. Targeted delivery of antisense oligonucleotides in cancer
14. Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with progression in human neuroblastoma
15. 1003PD - A multicentre phase II trial addressing lenalidomide (LEN) maintenance in patients with relapsed diffuse large b-cell lymphoma (rDLBCL) who are not eligible for autologous stem cell transplantation (ASCT)
16. 908O - High-dose methotrexate (HD-MTX) as CNS prophylaxis significantly improves outcome in patients with high-risk diffuse large B-cell lymphoma (DLBCL)
17. Combining CD23 chimeric antigen receptor immunotherapy and lenalidomide as a novel therapeutic strategy for chronic lymphocytic leukemia
18. 528 The BRD-inhibitor OTX015 Shows Pre-clinical Activity in Diffuse Large B-cell Lymphoma (DLBCL)
19. 210 Phospholipid Scramblase 1 Sensitizes Mantle Cell Lymphoma to Apoptosis Induced by Several Drugs
20. 353 ALK kinase controls an angiogenetic program in lymphoma, lung carcinoma and neuroblastoma
21. 57 High-resolution genomic profiling of 533 B-cell lymphomas defines distinct tumor signatures, genomic aberrations correlated with outcome and pathogenetic subgroups
22. 3 Pathogenesis of ocular adnexal lymphoma
23. Requirements for retroviral targeting of a suicide gene to alloreactive memory stem T cells for adoptive immunotherapy of leukemia
24. Chlamydia psittaci-eradicating antibiotic therapy in patients with advanced-stage ocular adnexal MALT lymphoma
25. 278 POSTER New curcumin analogues show enhanced antitumour activity in malignant melanoma cells
26. 232 POSTER Combined therapeutic effects of bortezomib and fenretinide on Neuroblastoma cell growth, apoptosis, and angiogenesis
27. 126 POSTER Novel phage display-derived peptides for tumor- and vascular- targeted therapies against neuroblastoma
28. 7009 POSTER Antiproliferative activity of eugenol and curcumin related biphenyls on malignant melanoma cell lines
29. 1403 ORAL Fenretinide enhances the antitumour efficacy of bortezomib on human neuroblastoma cells
30. Bacteria-eradicating therapy for ocular adnexal MALT lymphoma: questions for an open international prospective trial
31. Gastric MALT lymphomas prospective LY03 randomised cooperative trial: preliminary results of the molecular follow-up
32. Application of genomic real-time PCR to characterise 11q deletions in mantle cell lymphoma and chronic lymphocytic leukaemia
33. Inhibition of neuroblastoma-induced angiogenesis by fenretinide
34. Primary adult Western-type intestinal lymphoma (PAWIL) in immunocompetent patients: prognostic factors, patterns of relapse and therapeutic outcome
35. Modulation of α 1 β 1, α 2β 1, and α 3β 1 integrin heterodimers during human neuroblastoma cell differentiation
36. ARA-C induced differentiation of a new human neuroblastoma cell line (GI-ME-N)
37. Human neuroblastoma cells induced to differentiate with [formula omitted] show high levels of 2′,5′ oligoadenylate synthetase
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.